1. Home
  2. AYTU vs PEV Comparison

AYTU vs PEV Comparison

Compare AYTU & PEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • PEV
  • Stock Information
  • Founded
  • AYTU N/A
  • PEV 2002
  • Country
  • AYTU United States
  • PEV United States
  • Employees
  • AYTU N/A
  • PEV N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • PEV Auto Manufacturing
  • Sector
  • AYTU Health Care
  • PEV Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • PEV Nasdaq
  • Market Cap
  • AYTU 15.0M
  • PEV 15.8M
  • IPO Year
  • AYTU N/A
  • PEV 2022
  • Fundamental
  • Price
  • AYTU $2.24
  • PEV $0.81
  • Analyst Decision
  • AYTU
  • PEV
  • Analyst Count
  • AYTU 0
  • PEV 0
  • Target Price
  • AYTU N/A
  • PEV N/A
  • AVG Volume (30 Days)
  • AYTU 31.6K
  • PEV 14.8M
  • Earning Date
  • AYTU 11-12-2024
  • PEV 11-12-2024
  • Dividend Yield
  • AYTU N/A
  • PEV N/A
  • EPS Growth
  • AYTU N/A
  • PEV N/A
  • EPS
  • AYTU N/A
  • PEV N/A
  • Revenue
  • AYTU $81,002,000.00
  • PEV $10,761,000.00
  • Revenue This Year
  • AYTU N/A
  • PEV N/A
  • Revenue Next Year
  • AYTU N/A
  • PEV N/A
  • P/E Ratio
  • AYTU N/A
  • PEV N/A
  • Revenue Growth
  • AYTU N/A
  • PEV 97.81
  • 52 Week Low
  • AYTU $2.11
  • PEV $0.32
  • 52 Week High
  • AYTU $3.50
  • PEV $1.79
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 40.89
  • PEV 61.06
  • Support Level
  • AYTU $2.11
  • PEV $0.61
  • Resistance Level
  • AYTU $2.44
  • PEV $0.94
  • Average True Range (ATR)
  • AYTU 0.14
  • PEV 0.15
  • MACD
  • AYTU -0.02
  • PEV 0.04
  • Stochastic Oscillator
  • AYTU 17.57
  • PEV 44.78

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

About PEV Phoenix Motor Inc.

Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries. It designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium-duty electric vehicles (EVs) and markets and sells electric vehicle chargers for the commercial and residential markets. The company operates two primary brands, Phoenix Motorcars, which focuses on commercial products including medium-duty electric vehicles, chargers, and electric forklifts, and EdisonFuture which intends to offer light-duty electric vehicles.

Share on Social Networks: